FeldR. for the LCSG: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non small cell lung cancer.J. Natl. Cancer Inst., 85: 299–306, 1993.
2.
HolmesE.C. for the LCSG: Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.J. Clin. Oncol., 4: 710–715, 1986.
3.
KellerS.M., AdakS., WagnerH., HerskovicA., BrooksB.J., PerryM.C., LivingstonR.B., JohnsonD.H.: Prospective randomised trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIA non small cell lung cancer: an Intergroup Trial (E3590).Proc. Am. Soc. Clin. Oncol.,18: a465, 1999 (abstr. 1793).
4.
NiiranenA., Niitamo-KorhonnenS., KouriM., AssendelftA., MattsonK., PyrhonenS.: Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomised study.J. Clin. Oncol.,10: 1927, 1992.
5.
Non-Small Cell Lung Cancer Collaborative Group:Chemotherapy in non-small cell lung cancer: meta-analysis using updated data on individual patients from 52 randomized clinical trials.BMJ, 311: 899–909, 1995.
6.
OhtaM., TsuchiyaR., ShimoyamaM., SawamuraK., MoriT., MiyazawaN., SuemasuK., WatanabeY., TomitaM., TerashimaM.: Adjuvant chemotherapy for completely resected stage III non-small cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.J. Thorac. Cardiovasc. Surg., 106: 703–708, 1993.
7.
PORT Metaanalysis, Lancet, 352 (9124): 257–263, 1998.
8.
WadaH., HitomiS., TeramatsuT.: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.J. Clin. Oncol.,14: 1048–1054, 1996.
